Lexeo Therapeutics, Inc. Common Stock ( LXEO) - Stock Earnings
LXEO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -20.3 million USD | — USD |
| 2025Q4 | -20.9 million USD | — USD |
| 2026Q1 | -20.2 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
LXEO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -66.4 million USD | — USD |
| 2024 | -98.3 million USD | — USD |
| 2025 | -100.0 million USD | — USD |
| 2026 Est. | — | — |
LXEO
Price: $4.75
52 week price:
Earnings Per Share: -1.12 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 343.1 million